eBioMedicine – The Lancet Discovery Science
@ebiomedicine.bsky.social
360 followers 25 following 12 posts
Leading biomedical #openaccess journal, bridging the gap between basic and clinical research. Part of The Lancet Discovery Science. IF=9.7 🌐 https://www.thelancet.com/journals/ebiom/home
Posts Media Videos Starter Packs
ebiomedicine.bsky.social
A relatively new class of insecticide called “spatial emanators” offer protection from mosquito-borne diseases such as malaria, dengue, West Nile, yellow fever, and Zika. This meta-analysis of more than 25 years of research provides clarity on how to test these products and how well they work.
Volatile pyrethroid spatial repellents for preventing mosquito bites: a systematic review and meta-analysis
VPSRs offer protection from contact with mosquitoes, with semi-field studies reflecting field data and species-level differences observed. HLC provided the best quality data. Additional field studies ...
www.thelancet.com
Reposted by eBioMedicine – The Lancet Discovery Science
thelancet.com
First published in 1996, the CONSORT statement was designed to improve the quality of reporting and provide a minimum set of items to be included in a report of a randomised trial.

Now, there is an updated 2025 Statement.

Find it here: tinyurl.com/2s3hv3yx
Summary of main changes in CONSORT 2025. Copyright: 2025 The Author(s). Published by Elsevier Ltd. CC BY 4.0
Reposted by eBioMedicine – The Lancet Discovery Science
washingtonpost.com
A set of chemicals found in food packaging, plastics, and lotions and shampoos has been linked to hundreds of thousands of deaths from heart disease, according to a study published Tuesday in the journal eBioMedicine.
Common chemicals in plastic linked to over 350,000 deaths from heart disease
Researchers estimate that exposure to phthalates contributes to 13 percent of all heart disease deaths in people between 55 and 64 years old each year.
www.washingtonpost.com
Reposted by eBioMedicine – The Lancet Discovery Science
dngman.bsky.social
🩺🧠 ✨Excited about our latest work published in @ebiomedicine.bsky.social! In the BioFIND dataset, we found that brain activity provided unique information about progression to Alzheimer’s Disease (AD). #neuroskyence Paper: www.thelancet.com/journals/ebi...; Thread 🧶 ⤵️
Cover figure presenting main results from the paper. Left: altered spectral power and covariance difference between AD progressers and stable MCI patients. Right: multivariate analysis, highlighting the complementarity of MEG covariance spectra, MRI cortical volumes and baseline control measures.
ebiomedicine.bsky.social
🌙 New study on maternal sleep! 🌙 Using Fitbit data, researchers found: 🔹 Total sleep time peaks at 10 weeks of pregnancy. Light sleep ⬆️, deep & REM sleep ⬇️ Postpartum sleep deficits last 1.5 years
Clinicians can use this info to better support moms. 🤰🔬
Link in comments 👇 #MaternalHealth #Sleep
ebiomedicine.bsky.social
The March issue of eBioMedicine is now online! 🧬🔬 Hot off the press, exciting new #openaccess translational research on #obesity, #ibd, #t1d, #tuberculosis, #senolytics, and more!

📖🔍 Read now: all free, no paywall: www.thelancet.com/journals/ebi...
ebiomedicine.bsky.social
Exciting new Lancet role ✨

This autumn, our Group is launching an OA journal dedicated to the unique health challenges on the African continent: The Lancet Regional Health—Africa 🌍 To lead this important endeavour, we are searching for an Editor-in-Chief. Find out more & apply ⤵️ bit.ly/3Xp919w
Editor-in-Chief, The Lancet Regional Health - Africa
Do you enjoy using science to drive change in the world? Would you like to develop and launch an online-only gold open access journal for The Lancet. About our Team The Lancet Regional Health -Africa ...
bit.ly
ebiomedicine.bsky.social
The February issue of eBioMedicine is live! On the cover:
✒️ Editorial: Wildfires, smog, and the threat of #airpollution to health🫁 Research: Epithelial stem cells for #IPF therapy
🧠 Review: Synapse vulnerability in #Alzheimer’s disease
Read #openaccess 👇https://www.thelancet.com/journals/ebiom/home
eBioMedicine Home Page
eBioMedicine is a leading biomedical open access journal, bridging the gap between basic and clinical research, published by The Lancet.
www.thelancet.com